Leukemia, Chronic Myeloid Clinical Trial
Official title:
Prospective Observational Cohort Registry for Patients With Chronic Myeloid Leukemia at Asan Medical Center
The investigators would like to propose a prospective longitudinal observational cohort study for patients who will be diagnosed and/or treated for chronic myeloid leukemia at Asan Medical Center, Seoul, Korea, to use the acquired data for fundamentals of other retrospective analysis.
1. Acquisition of informed concent form
2. Data acquisition from medical record including
- demographic / disease-associated factors
- details of treatment, and its results
- complications during treatment
- genetic data
- survival outcome (upto 30 years)
3. Accumulation of data for 30 years
4. Use of data for other retrospective analysis (including Asan Medical center Cell Banking
basic data)
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04384848 -
The EMPATHY Pilot Study
|
N/A | |
| Recruiting |
NCT03515018 -
Evaluation of the Therapeutic Effect of HU Pulse Therapy for CML Patients
|
Phase 3 | |
| Active, not recruiting |
NCT02381379 -
Malaysia Stop Tyrosine Kinase Inhibitor Trial
|
Phase 3 | |
| Active, not recruiting |
NCT02852486 -
Study of Imatinib Discontinuation in Chronic Myeloid Leukemia With Deep Molecular Response
|
Phase 2 | |
| Recruiting |
NCT02326311 -
Optimization of TKIs Treatment and Quality of Life in Ph+ CML Patients ≥60 Years in Deep Molecular Response
|
Phase 3 | |
| Terminated |
NCT02627573 -
Trial of GVHD Prophylasxis With PTCy or Thymoglobulin in Unrelated SCT
|
Phase 2 | |
| Withdrawn |
NCT02973711 -
A Study of Ruxolitinib in Combination With Nilotinib in Patients With Chronic Phase CML
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT02389920 -
Multicenter, PhaseⅣ, Open Label Trial of Nilotinib in Adult Patients Diagnosed Philadelphia Chromosome Positive(Ph+) Chronic Myeloid Leukemia in CP/AP Intolerant to Dasatinib
|
Phase 4 |